Searched for
TB ALLIANCE
Viatris cuts price of TB drug by 34%The decision to cut the price will help to expand access to a critical new treatment in more than 140 countries, including India, which has...- WHO: Tuberculosis cases rise for the first time in yearsThe COVID-19 pandemic disrupted services for people with TB along with many other health programs. WHO said many people went undiagnosed, n...
- Urgency lacking as TB passes Covid as biggest killer: ExpertTuberculosis, once called consumption, was the world's biggest infectious killer before the arrival of Covid-19, with 1.5 million people dy...
- TB Alliance in talks with government over use of new shorter BPaL RegimenIndia has the world's highest TB burden-- 2.6 million active cases and close to 450,000 deaths each year from the infectious bacterial dise...
- Lupin, TB Alliance join hands for new therapy for drug-resistant tuberculosisTB Alliance President and CEO Mel Spigelman said that partnering with Lupin -- a well-established manufacturer with experience delivering h...
- BPaL regimen can cut time for treatment of drug-resistant TBBPaL is a six-month, alloral, three-drug regimen that is used to treat people with highly drug-resistant forms of TB. It consists of the TB...
- Mylan gets DCGI nod for anti-tuberculosis drug Pretomanid for conditional accessThe Drug Controller General of India (DCGI) has approved Pretomanid for conditional access under the National Tuberculosis Elimination Prog...
- Mylan, TB Alliance seeks clinical trial waiver for Pretomanid drugPretomanid, a new oral treatment is a shorter more convenient option for people with extensively drug resistant (XDR) TB. The dossier for g...
- Mumbai pharma company gets licence for breakthrough TB drugA global non-profit drug developer TB Alliance has tied up with domestic company Macleods Pharmaceuticals to develop and commercialise its ...
- Mylan working with DCGI to launch new TB drug in IndiaMylan will be in a position to launch the product in India soon after receiving approvals from DCGI," Mylans global president and executive...
- New treatment to be made affordable for patients: TB AlliancePretomanid is the third TB drug to have been approved by the USFDA in the last 40 years.
- USFDA okays new antibiotic for highly drug-resistant tuberculosisPretomanid, a new chemical entity, was under development since 2002 by the TB Alliance.
- Driving innovation: Global fund fosters partnership between India & UK to combat health challengesThe Global Fund was created in 2002. With public donors including the USA, UK, and private donors such as the Gates Foundation, it has used...
- States must invest in R&D to fund new drug discoveries: TB AllianceGeneric manufacturers are essential players in the fight to end TB so we do speak with generic manufacturers as part of our access strategy.
- Drug combo speeds up TB treatmentThe drug combination, known as PaMZ, killed more bacteria than standard treatment and was effective in treating drug-resistant tuberculosis.
- World TB day: Need to raise public spend on clinical trials & find innovative ways to incentivise R&DMarch 24 is World TB day. It commemorates the discovery of Tuberculosis (TB) bacillus in 1883 by Dr Robert Koch as the cause of tuberculosi...
- 1/3rd pvt sector TB drugs outside treatment recommendations: StudyAt least one-third of all private sector dosages of first line TB drugs across the 10 high TB burdened countries fall outside treatment rec...
- Two new TB drugs enter advanced stages of clinical trialTwo new drugs against tuberculosis have reached the advanced stages of clinical trial and could be made available for use by 2012-2014.
- Eli Lilly to invest $50m in TB eradication allianceEli Lilly and Co will invest an additional $50 million in Lilly Multi-Drug Resistant Tuberculosis (MDR-TB) Partnership, a global TB eradica...
- Eli Lilly & co announces partnership to fight MDR-TBEli Lilly and Company has announced plans to invest an additional $50 million in a global partnership to fight Multi-Drug Resistant Tubercu...
Load More
